IGFBP3 inhibits tumor growth and invasion of lung cancer cells and is associated with improved survival in lung cancer patients
The insulin-like growth factor (IGF)-pathway is involved in tumor cell proliferation, metastasis, and survival. We aimed to find out what effects IGF binding protein 3 (IGFBP3) exerted on H1299 lung cancer (LC) cells in terms of tumor growth and invasion and whether IGFBP3 was associated with clinic...
Main Authors: | Hartmut Kuhn, Armin Frille, Marie Anna Petersen, Jonas Oberhuber-Kurth, Lukas Hofmann, Albrecht Gläser, Sabine Taubenheim, Sabine Klagges, Sebastian Kraemer, Johannes Broschewitz, Maximilian von Laffert, Hubert Wirtz |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652332200225X |
Similar Items
-
TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations
by: Armin Frille, et al.
Published: (2024-04-01) -
Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial
by: Armin Frille, et al.
Published: (2020-03-01) -
IGFBP-4: A promising biomarker for lung cancer
by: Nur Savas Irem, et al.
Published: (2021-01-01) -
Associations of aspirin, statins and metformin with lung cancer risk and related mortality
by: Armin Frille, et al.
Published: (2021-06-01) -
CT texture analysis and node-RADS CT score of mediastinal lymph nodes - diagnostic performance in lung cancer patients
by: Hans-Jonas Meyer, et al.
Published: (2022-12-01)